Meg Tirrell covers medicine and biotechnology for CNBC. She appears on CNBC’s Business Day programming, contributes to CNBC.com and is based at the network’s global headquarters in Englewood Cliffs, N.J.
Tirrell has covered development of new drugs for Alzheimer’s, cancer and rare diseases, and tracked public health emergencies from Ebola to Zika. Her work has explored why fewer drugs are developed for children, chronicled the sequencing of her own genome, and revealed the impact of escalating drug prices on patients, municipalities and the health-care system. Her series, Modern Medicine, plumbs the biggest developments in the way we treat disease.
Prior to joining CNBC in April 2014, Tirrell covered the biotechnology industry for Bloomberg News, where she also contributed to Bloomberg Television and Bloomberg Businessweek.
She holds a master’s degree in journalism from Northwestern University and a bachelor’s degree in English and music from Wellesley College.
Follow her on Twitter @megtirrell.